Tags : Clinical Trial Agreement


Genome & Company Signs a Clinical Trial Agreement with Merck

Shots: Genome & Company enters into a clinical trial and supply agreement with Merck KGaA and Pfizer to evaluate the safety, tolerability, biological and clinical activities of GEN-001 + Bavencio (avelumab) for multiple cancer indications Genome & Company will sponsor the study while Merck KGaA will supply avelumab in P-I/Ib study which is expected to […]Read More